AW
STRO icon

Avion Wealth’s Sutro Biopharma STRO Stock Holding History

Avion Wealth’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Sell
46
-26
-36% -$811 ﹤0.01% 1343
2026
Q1 		$1K Hold
72
– – ﹤0.01% 1142
2025
Q4 		$0 Hold
72
– – ﹤0.01% 1570
2025
Q3 		$0 Hold
72
– – ﹤0.01% 1537
2025
Q2 		$0 Buy
+72
New +$589 ﹤0.01% 1587

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Avion Wealth's STRO Position: Q2 2026 in Review

Avion Wealth reduced its Sutro Biopharma (STRO) stake by 36% in Q2 2026, selling an estimated $811 and leaving 46 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1343.

Avion Wealth first reported a position in STRO in Q2 2025 and has held it in 5 quarters since. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • Avion Wealth held 46 shares of Sutro Biopharma worth $1K as of Q2 2026.
  • Avion Wealth sold 26 Sutro Biopharma shares in Q2 2026, an estimated $811.
  • Sutro Biopharma made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1343 holding.
  • Avion Wealth first reported a position in Sutro Biopharma in Q2 2025 and has held it in 5 quarters since.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.